ASHLEY REMORIN: Open Payments
NPI 1639833536 · CREVE COEUR, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 34 payments from 14 companies in 2025. Trend: 2023 $111 · 2024 $331 · 2025 $846
Food & beverage: $846
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $173 |
| Boston Scientific Corporation | 1 | $148 |
| PFIZER INC. | 5 | $134 |
| BridgeBio Pharma, Inc. | 3 | $69 |
| Esperion Therapeutics, Inc. | 3 | $62 |
| HEARTFLOW, INC. | 3 | $55 |
| Lilly USA, LLC | 2 | $39 |
| Novo Nordisk Inc | 2 | $37 |
| Amgen Inc. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
Products named: LifeVest, WATCHMAN Access System, VYNDAQEL, Attruby, NEXLETOL, FFRct, MOUNJARO, REPATHA.
Industry payments across MO — which companies pay providers there.
